Quarterly report pursuant to Section 13 or 15(d)

Liquidity and Financial Condition (Details)

v3.22.2.2
Liquidity and Financial Condition (Details) - USD ($)
 1 Months Ended 6 Months Ended
Mar. 30, 2022
Mar. 23, 2022
Jun. 30, 2022
Dec. 16, 2020
Liquidity and Financial Condition (Details) [Line Items]        
Accumulated deficit     $ 82,700,000  
Working capital     700,000  
Net loss     9,000,000  
Net cash used in operating activities     $ 5,900,000  
Irrevocable standby letter of credit.   $ 10,000,000    
Accrues interest rate   12.00%    
Maturity term   2 years    
Shares of restricted common stock (in Shares)   50,000    
Restricted cash draw   $ 1,000,000    
Drawdown amount   $ 5,000,000    
Aggregate gross proceed percentage 3.00%      
Sale of net proceed (in Shares)     51,169  
Agreement of sales     $ 57,574  
commissions and expenses     $ 2,124  
Weighted average price (in Dollars per share)     $ 1.17  
Shares issued (in Shares)       5,333,333
Common Stock [Member]        
Liquidity and Financial Condition (Details) [Line Items]        
Issued warrants shares of common stock (in Shares)   200,000    
Exercise price (in Dollars per share)   $ 2    
Placement Shares [Member]        
Liquidity and Financial Condition (Details) [Line Items]        
Sale of shares (in Shares) 5,000,000      
Series D Preferred Stock [Member]        
Liquidity and Financial Condition (Details) [Line Items]        
Shares liability     $ 1,100,000  
Shares issued (in Shares)     1,058